PATIENTS OF HIGH AGE WITH ADVANCED TRANSITIONAL CELL-CARCINOMA TREATED BY M-VAC CHEMOTHERAPY

被引:2
|
作者
SAGASTER, P
FLAMM, J
ESSL, R
TEICH, G
机构
关键词
D O I
10.1055/s-2008-1061473
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:325 / 329
页数:5
相关论文
共 50 条
  • [1] HISTOPATHOLOGIC CHANGES OF TRANSITIONAL CELL-CARCINOMA OF BLADDER AFTER M-VAC CHEMOTHERAPY
    JAVADPOUR, N
    DALONI, P
    UROLOGY, 1989, 34 (06) : 357 - 359
  • [2] M-VAC AS SALVAGE CHEMOTHERAPY IN TRANSITIONAL CELL-CARCINOMA (TCC) OF THE UROTHELIUM PREVIOUSLY TREATED WITH CISPLATIN COMBINATION CHEMOTHERAPY
    CHONG, C
    LOGOTHETIS, CJ
    DEXEUS, FH
    SELLA, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 204 - 204
  • [3] M-VAC OR MVC FOR THE TREATMENT OF ADVANCED TRANSITIONAL CELL-CARCINOMA - METASTATIC, INDUCTION, AND ADJUVANT
    SOLOWAY, MS
    ISHIKAWA, S
    TAYLOR, T
    EZELL, G
    JOURNAL OF SURGICAL ONCOLOGY, 1989, : 40 - 45
  • [4] M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN) FOR ADVANCED TRANSITIONAL CELL-CARCINOMA OF THE UROTHELIUM
    STERNBERG, CN
    YAGODA, A
    SCHER, HI
    WATSON, RC
    HERR, HW
    MORSE, MJ
    SOGANI, PC
    VAUGHAN, ED
    BANDER, N
    WEISELBERG, LR
    GELLER, N
    HOLLANDER, PS
    LIPPERMAN, R
    FAIR, WR
    WHITMORE, WF
    JOURNAL OF UROLOGY, 1988, 139 (03): : 461 - 469
  • [5] INITIAL EXPERIENCE WITH M-VAC FOR METASTATIC TRANSITIONAL CELL-CARCINOMA (TCC)
    SHEEHAN, R
    SAGALOWSKY, AI
    BALABAN, E
    COX, J
    JOURNAL OF UROLOGY, 1987, 137 (04): : A270 - A270
  • [6] CLINICAL DOWNSTAGING AFTER NEOADJUVANT M-VAC FOR TRANSITIONAL CELL-CARCINOMA OF THE UROTHELIUM
    SCHER, HI
    FAIR, WR
    YAGODA, A
    STERNBERG, CN
    MORSE, MJ
    HERR, HW
    SOGANI, PC
    HOLLANDER, PS
    WHITMORE, WF
    JOURNAL OF UROLOGY, 1987, 137 (04): : A157 - A157
  • [7] Maintenance chemotherapy with gemcitabine and paclitaxel for M-VAC refractory metastatic transitional cell carcinoma
    Kawai, K
    Oikawa, T
    Sekido, N
    Hinotsu, S
    Hattori, K
    Miyanaga, N
    Shimazui, T
    Akaza, H
    JOURNAL OF UROLOGY, 2005, 173 (04): : 360 - 360
  • [8] M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN) CHEMOTHERAPY FOR TRANSITIONAL CELL-CARCINOMA - THE PRINCESS-MARGARET-HOSPITAL EXPERIENCE
    TANNOCK, I
    GOSPODAROWICZ, M
    CONNOLLY, J
    JEWETT, M
    JOURNAL OF UROLOGY, 1989, 142 (02): : 289 - 292
  • [9] M-VAC CHEMOTHERAPY AND SURGERY FOR ADVANCED BLADDER-CARCINOMA
    HERR, HW
    YAGODA, A
    STERNBERG, CN
    WHITMORE, WF
    SCHER, HI
    SOGANI, PC
    MORSE, MJ
    FAIR, WR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (02): : 104 - 105
  • [10] NEOADJUVANT M-VAC WITH INTRAARTERIAL (IA) CISPLATIN IN LOCALLY ADVANCED TRANSITIONAL CELL-CARCINOMA OF THE BLADDER - PHASE I/II TRIAL
    BUKOWSKI, RM
    MONTIE, JE
    LEE, M
    GANAPATHI, R
    JOURNAL OF UROLOGY, 1987, 137 (04): : A156 - A156